PURPOSE: Retinal ischemia-associated ocular disorders, such as retinal occlusive disorders, neovascular age-related macular degeneration, proliferative diabetic retinopathy, and glaucoma are vision-threatening. In this study, we examined whether and by what mechanisms resveratrol, a polyphenol found in red wine, is able to protect against retinal ischemia/reperfusion injury. METHODS: In vivo rat retinal ischemia was induced by high intraocular pressure (HIOP), namely, 120 mmHg for 60 min. The mechanism and management was evaluated by electroretinogram (ERG) b-wave amplitudes measurement, immunohistochemistry, and real-time polymerase chain reaction. RESULTS: The HIOP-induced retinal ischemic changes were characterized by a decrease in ERG b-wave amplitudes, a loss of choline acetyltransferase immunolabeling of amacrine cell bodies/neuronal processes, and increased vimentin immunoreactivity, which is a marker of Müller cells, together with upregulation of matrix metalloproteinase-9 (MMP-9), heme oxygenase-1 (HO-1), and inducible nitric oxide (iNOS), and downregulation of Thy-1, both at the mRNA level. The detrimental effects due to the ischemia were concentration-dependent (weaker effect at 0.05 nmole) and/or significantly (at 0.5 nmole) altered when resveratrol was applied 15 min before or after retina ischemia. CONCLUSION: This study supports the hypothesis that resveratrol may be able to protect the retina against ischemia by downregulation of MMP-9 and iNOS, and upregulation of HO-1.
PURPOSE:Retinal ischemia-associated ocular disorders, such as retinal occlusive disorders, neovascular age-related macular degeneration, proliferative diabetic retinopathy, and glaucoma are vision-threatening. In this study, we examined whether and by what mechanisms resveratrol, a polyphenol found in red wine, is able to protect against retinal ischemia/reperfusion injury. METHODS: In vivo ratretinal ischemia was induced by high intraocular pressure (HIOP), namely, 120 mmHg for 60 min. The mechanism and management was evaluated by electroretinogram (ERG) b-wave amplitudes measurement, immunohistochemistry, and real-time polymerase chain reaction. RESULTS: The HIOP-induced retinal ischemic changes were characterized by a decrease in ERG b-wave amplitudes, a loss of choline acetyltransferase immunolabeling of amacrine cell bodies/neuronal processes, and increased vimentin immunoreactivity, which is a marker of Müller cells, together with upregulation of matrix metalloproteinase-9 (MMP-9), heme oxygenase-1 (HO-1), and inducible nitric oxide (iNOS), and downregulation of Thy-1, both at the mRNA level. The detrimental effects due to the ischemia were concentration-dependent (weaker effect at 0.05 nmole) and/or significantly (at 0.5 nmole) altered when resveratrol was applied 15 min before or after retina ischemia. CONCLUSION: This study supports the hypothesis that resveratrol may be able to protect the retina against ischemia by downregulation of MMP-9 and iNOS, and upregulation of HO-1.
Authors: Noritake Miyamura; Tsukihiko Ogawa; Sharon Boylan; Lawrence S Morse; James T Handa; Leonard M Hjelmeland Journal: Invest Ophthalmol Vis Sci Date: 2004-05 Impact factor: 4.799
Authors: Margrit Hollborn; Christina Stathopoulos; Anja Steffen; Peter Wiedemann; Leon Kohen; Andreas Bringmann Journal: Invest Ophthalmol Vis Sci Date: 2007-09 Impact factor: 4.799
Authors: María Victoria Bariani; Fernando Correa; Emma Leishman; Ana Paula Domínguez Rubio; Andreína Arias; Aníbal Stern; Heather B Bradshaw; Ana María Franchi Journal: Mol Hum Reprod Date: 2017-08-01 Impact factor: 4.025
Authors: Ahmed Y Shanab; Sally L Elshaer; Mona F El-Azab; Sahar Soliman; Harika Sabbineni; Suraporn Matragoon; Susan C Fagan; Azza B El-Remessy Journal: Angiogenesis Date: 2014-11-25 Impact factor: 9.596
Authors: Mika Reinisalo; Anna Kårlund; Ali Koskela; Kai Kaarniranta; Reijo O Karjalainen Journal: Oxid Med Cell Longev Date: 2015-06-09 Impact factor: 6.543